Oslo Cancer Cluster has highlighted ten of their Norwegian members who caught their attention this year.

Despite the challenges with the corona pandemic, several of Oslo Cancer Cluster’s members have distinguished themselves with good news and positive updates throughout the year.

“The corona pandemic made 2020 a challenging year for many companies, but the health industry showed a remarkable ability to adapt to the new circumstances. For companies running clinical trials, two major challenges have been restricted access to hospitals, which forced a temporary stop to clinical trials in March, and disruptions to the global supply chain,” they state.

For that reason, Oslo Cancer Cluster has highlighted ten of our Norwegian members (in alphabetical order) who caught our attention this year.

Read the ten highlights here!

Photo of Rafig Hasan, CEO of Exact Therapeutics, one of the companies’ highlighted by Oslo Cancer Cluster